Perspective Therapeutics, Inc. (CATX)

PHARMACEUTICAL PREPARATIONS

Perspective Therapeutics, Inc. (CATX) is listed on NYSE American, where it has traded since December 29, 2003.

Listed On
NYSE American
Listed Since
December 29, 2003
Employees
166
Market Cap
$184M

About Perspective Therapeutics, Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 128 institutions reported holding CATX, with 87.2 million shares worth $297.6 million in aggregate. The largest reported holder was BlackRock, with 9.5 million shares worth $32.4 million. Of the 5 largest holders listed below, 3 added shares and 2 held their positions unchanged during the quarter.

InstitutionSharesValueQuarter change
BlackRock9,494,152$32MAdded 77.51%
Tcg Crossover Management7,915,567$27MUnchanged
Commodore Capital6,336,782$22MUnchanged
Avidity Partners Management6,299,999$21MAdded 4.13%
Vanguard6,149,831$21MAdded 6.55%

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is CATX?

Perspective Therapeutics, Inc. (CATX) is listed on NYSE American, where it has traded since December 29, 2003.

Who are the largest institutional holders of CATX?

In 13F filings for the quarter ended June 30, 2026, the largest reported holders of CATX were BlackRock, Tcg Crossover Management and Commodore Capital.

How many institutions own CATX?

128 institutions reported a position in CATX for the quarter ended June 30, 2026, worth $297.6 million in total.

Did institutions buy or sell CATX last quarter?

Of the 5 largest reported holders, 3 added shares and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for CATX.

Every reported institutional holder, plus insider and congressional trades in CATX, on SentiSense.